Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Bristol-Myers Squibb
USWM, LLC (dba US WorldMeds)
Memorial Sloan Kettering Cancer Center
Modulation Therapeutics, Inc.
Pfizer
National Cancer Institute (NCI)
Mayo Clinic
H. Lee Moffitt Cancer Center and Research Institute
University of Oklahoma
Werewolf Therapeutics, Inc.
ModernaTX, Inc.
Pierre Fabre Medicament
Regeneron Pharmaceuticals
Melanoma Institute Australia
Institut Curie
BioInvent International AB
Indiana University
Leiden University Medical Center
Immuneering Corporation
Sensei Biotherapeutics, Inc.
BioAtla, Inc.
Immunophotonics, Inc.
Salubris Biotherapeutics Inc
Adaptimmune